Development and Implementation of an e-Trigger Tool for Adverse Drug Events in a Swiss University Hospital

被引:6
|
作者
El Saghir, Amina [1 ,2 ]
Dimitriou, Georgios [2 ,3 ]
Scholer, Miriam [4 ]
Istampoulouoglou, Ioanna [1 ,2 ]
Heinrich, Patrick [4 ]
Baumgartl, Klaus [4 ]
Schwendimann, Rene [5 ]
Bassetti, Stefano [2 ,3 ]
Leuppi-Taegtmeyer, Anne [1 ,2 ]
机构
[1] Univ Hosp, Dept Clin Pharmacol & Toxicol, Basel, Switzerland
[2] Univ Basel, Basel, Switzerland
[3] Univ Hosp, Div Internal Med, Basel, Switzerland
[4] Univ Hosp Basel, Dept Informat Technol, Basel, Switzerland
[5] Univ Hosp Basel, Patient Safety Off, Basel, Switzerland
来源
关键词
electronic health record; medication module; drug safety; patient safety; digital health; PERFORMANCE; METHODOLOGY; ACCURACY; CARE;
D O I
10.2147/DHPS.S334987
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Purpose: The purpose of the study was to develop and implement an institution-specific trigger tool based on the Institute for Healthcare Improvement medication module trigger tool (IHI MMTT) in order to detect and monitor ADEs. Methods: We performed an investigator-driven, single-center study using retrospective and prospective patient data to develop ("development phase") and implement ("implementation phase") an efficient, institution-specific trigger tool based on the IHI MMTT. Complete medical data from 1008 patients hospitalized in 2018 were used in the development phase. ADEs were identified by chart review. The performance of two versions of the tool was assessed by comparing their sensitivities and specificities. Tool A employed only digitally extracted triggers ("e-trigger-tool") while Tool B employed an additional manually extracted trigger. The superior tool - taking efficiency into account - was applied prospectively to 19-22 randomly chosen charts per month for 26 months during the implementation phase. Results: In the development phase, 189 (19%) patients had >= 1 ADE (total 277 ADEs). The time needed to identify these ADEs was 15 minutes/chart. A total of 203 patients had >= 1 trigger (total 273 triggers - Tool B). The sensitivities and specificities of Tools A and B were 0.41 and 0.86, and 0.43 and 0.86, respectively. Tool A was more time-efficient than Tool B (4 vs 9 minutes/chart) and was therefore used in the implementation phase. During the 26-month implementation phase, 22 patients experienced trigger-identified ADEs and 529 did not. The median number of ADEs per 1000 patient days was 6 (range 0-13). Patients with at least one ADE had a mean hospital stay of 22.3 +/- 19.7 days, compared to 8.0 +/- 7.6 days for those without an ADE (p = 2.7810(-14)). Conclusion: We developed and implemented an e-trigger tool that was specific and moderately sensitive, gave consistent results and required minimal resources.
引用
收藏
页码:251 / 263
页数:13
相关论文
共 50 条
  • [1] Adverse drug events in hospital: pilot study with trigger tool
    Rozenfeld, Suely
    Giordani, Fabiola
    Coelho, Sonia
    [J]. REVISTA DE SAUDE PUBLICA, 2013, 47 (06): : 1102 - 1111
  • [2] Performance of the Adverse Drug Event Trigger Tool and the Global Trigger Tool for Identifying Adverse Drug Events: Experience in a Belgian Hospital
    Carnevali, Lise
    Krug, Bruno
    Amant, Fabienne
    Van Pee, Dominique
    Gerard, Veronique
    de Bethune, Xavier
    Spinewine, Anne
    [J]. ANNALS OF PHARMACOTHERAPY, 2013, 47 (11) : 1414 - 1419
  • [3] Adverse Drug Events Identified by Global Trigger Tool at a University Hospital: a Retrospective Medical Record Review
    Hu, Q. Z.
    Zhan, M.
    Wu, B.
    Xu, T.
    [J]. JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2017, 65 : S351 - S352
  • [4] Development of a Trigger Tool to Identify Adverse Drug Events in Elderly Patients With Multimorbidity
    Toscano Guzman, Maria Dolores
    Galvan Banqueri, Mercedes
    Jose Otero, Maria
    Alfaro Lara, Eva Rocio
    Casajus Lagranja, Pilar
    Santos Ramos, Bernardo
    [J]. JOURNAL OF PATIENT SAFETY, 2021, 17 (06) : e475 - e482
  • [6] Flumazenil as Trigger Tool for Measuring Adverse Drug Events
    Ng, Sock Ping
    Wu, Hsiu Ling
    Talbot, Alan Ronaldmp
    Chien, Su Yu
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2014, 23 : 420 - 420
  • [7] Adverse events identified by the global trigger tool at a university hospital: A retrospective medical record review
    Hu, Qiaozhi
    Wu, Bin
    Zhan, Mei
    Jia, Weiguo
    Huang, Yimei
    Xu, Ting
    [J]. JOURNAL OF EVIDENCE BASED MEDICINE, 2019, 12 (02) : 91 - 97
  • [8] Establishment of a pediatric trigger tool based on Global Trigger Tool to identify adverse drug events of children: experience in a Chinese hospital
    Yi Liu
    Junfeng Yan
    Yunfei Xie
    Yuan Bian
    [J]. BMC Pediatrics, 20
  • [9] Establishment of a pediatric trigger tool based on Global Trigger Tool to identify adverse drug events of children: experience in a Chinese hospital
    Liu, Yi
    Yan, Junfeng
    Xie, Yunfei
    Bian, Yuan
    [J]. BMC PEDIATRICS, 2020, 20 (01)
  • [10] Detection of adverse drug events using an electronic trigger tool
    Lim, Dennison
    Melucci, Joe
    Rizer, Milisa K.
    Prier, Beth E.
    Weber, Robert J.
    [J]. AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2016, 73 (17) : S112 - S120